Aristippos Gennadios, President Softgel & Oral Technology at Catalent, Inc. (CTLT), sold 4,353 shares at $131.20 ($571K) on 2021-08-27, disclosed to the SEC on 2021-08-30.
Seasonal sale ($571k) by President Softgel & Oral Technology — this insider has traded CTLT in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $130.29 | 171 | $22K | 3.9% |
| 2 | $131.20 | 2,091 | $274K | 48.0% |
| 3 | $131.20 | 2,091 | $274K | 48.0% |
| Total | $131.16 avg | 4,353 | $571K | 100% |
| Filing → |
| CTLT | SELL | 2023-08-25 | $18K | — | Filing → |
| CTLT | SELL | 2023-08-03 | $13K | — | Filing → |
| CTLT | SELL | 2022-08-26 | $339K | — | Filing → |